Latest Institutional Transactions on Keros Therapeutics, Inc. (KROS)
This table provides information on the latest institutional transactions involving Keros Therapeutics, Inc. (KROS) stock. The table includes the name of the institution, the type of operation (buy or sell), whether options were involved, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the transaction has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 28, 2021
Q4 2020
|
Telemus Capital, LLC
|
SELL
|
- |
-15KClosed |
$540K - $1.24M
|
0
$0
|
|
| Q3 2020 | |||||||
|
Nov 16, 2020
Q3 2020
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-300KClosed |
$8.11M - $18.7M
|
0
$0
|
|
|
Nov 16, 2020
Q3 2020
|
Zimmer Partners, LP
New York, NY |
SELL
|
- |
-15.9KClosed |
$430K - $988K
|
0
$0
|
|
|
Nov 12, 2020
Q3 2020
|
Pathstone Family Office, LLC
Englewood, NJ |
SELL
|
- |
-1.27KClosed |
$34.3K - $78.8K
|
0
$0
|
|